Brief: Titan Pharmaceuticals Announces Pricing Of $2.7 Million Registered Direct Offering
24/09/2020 14:05
Sept 24 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES PRICING OF $2.7 MILLION
REGISTERED DIRECT OFFERING
* TITAN PHARMACEUTICALS INC - ENTERED INTO SHARE PURCHASE
AGREEMENT OF 19.4 MILLION SHARES AT A PURCHASE PRICE OF $0.14
PER SHARE
Source text for Eikon: ID:nPn1669Xka
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.